Pemetrexed (Page 8 of 8)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0480-4516-01

Pemetrexed Injection
100 mg/4 mL
(25 mg/mL)

Must Dilute Before Intravenous Infusion

Do not mix with calcium-containing infusion solutions.

Store refrigerated

Discard unused portion.

CAUTION: Cytotoxic Agent

Rx Only

4 mLSingle-Dose Vial

1
(click image for full-size original)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0480-4514-01

Pemetrexed Injection
500 mg/20 mL
(25 mg/mL)

Must Dilute Before Intravenous Infusion

Do not mix with calcium-containing infusion solutions.

Store refrigerated

Discard unused portion.

CAUTION: Cytotoxic Agent

Rx Only

20 mLSingle-Dose Vial

1
(click image for full-size original)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0480-4515-01

Pemetrexed Injection
1 g/40 mL
(25 mg/mL)

Must Dilute Before Intravenous Infusion

Do not mix with calcium-containing infusion solutions.

Store refrigerated

Discard unused portion.

CAUTION: Cytotoxic Agent

Rx Only

40 mLSingle-Dose Vial

1
(click image for full-size original)
PEMETREXED pemetrexed solution, concentrate
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0480-4516
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PEMETREXED MONOHYDRATE (PEMETREXED) PEMETREXED MONOHYDRATE 25 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
TROMETHAMINE
ANHYDROUS CITRIC ACID
METHIONINE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0480-4516-01 1 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE
1 4 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (0480-4516-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA208419 06/01/2022
PEMETREXED pemetrexed solution, concentrate
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0480-4514
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PEMETREXED MONOHYDRATE (PEMETREXED) PEMETREXED MONOHYDRATE 25 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
TROMETHAMINE
ANHYDROUS CITRIC ACID
METHIONINE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0480-4514-01 1 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE
1 20 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (0480-4514-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA208419 05/31/2022
PEMETREXED pemetrexed solution, concentrate
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0480-4515
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PEMETREXED MONOHYDRATE (PEMETREXED) PEMETREXED MONOHYDRATE 25 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
TROMETHAMINE
ANHYDROUS CITRIC ACID
METHIONINE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0480-4515-01 1 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE
1 40 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (0480-4515-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA208419 05/31/2022
Labeler — Teva Pharmaceuticals, Inc. (022629579)

Revised: 12/2022 Teva Pharmaceuticals, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.